article thumbnail

Novartis leads race to acquire Monjuvi maker MorphoSys: Reuters

Fierce Pharma

After Novartis reportedly backed out of late-stage talks to acquire Cytoki | The company has a leading bid for the cancer drug maker over Incyte, Reuters reports, citing two people familiar with the matter.

Leads 231
article thumbnail

Leading AstraZeneca investor defends CEO pay ahead of shareholder vote: FT

Fierce Pharma

Leading AstraZeneca investor defends CEO pay ahead of shareholder vote: FT zbecker Wed, 04/10/2024 - 10:49

Leads 146
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

JPM24: Riding label expansions and launches, AZ plots course toward 'industry-leading growth' by 2030

Fierce Pharma

In AZ's push to reach industry-leading growth by 2030, confidence is key, chief financial officer Aradhana Sarin said at the J.P. With a late-stage pipeline spanning more than 120 clinical trials and a firm grasp of five major disease areas, AstraZeneca appears confident heading into 2024. | Morgan Healthcare Conference.

Leads 280
article thumbnail

Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4

Fierce Pharma

In a year that started with more than two-thirds of biopharma companies posting | While Novo Nordisk and Eli Lilly continued to be the biopharma industry growth leaders in the fourth quarter of 2023, many other drugmakers also delivered big gains, including Daiichi Sankyo, Amgen, Teva, GSK and Novartis.

Leads 286
article thumbnail

Marketing-Led Post-COVID-19 Growth Strategies

When the dust settles, we have a responsibility to turn our shock and grief into fierce determination and lead the charge of responsible, strategic, and sustainable future growth. However, there’s no team better suited to lead that charge than the marketing department. Getting consensus on how to define “qualified leads”.

article thumbnail

Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US

Fierce Pharma

Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56

Leads 263
article thumbnail

Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment

European Pharmaceutical Review

The post Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment appeared first on European Pharmaceutical Review. Gepotidacin is an investigational bactericidal, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a novel mechanism of action, according to GSK.

Leads 70
article thumbnail

The Ultimate Guide to Sales Outreach

In this eBook, we’ll cover: How you should respond to inbound leads Tactics for engaging outbound leads (cold calls, email automation, and gifts) The key to keeping a prospective account alive for the long haul Buckle up! The art is what you bring to the table—your flair for conversation, your work ethic, your dedication.

article thumbnail

Forrester Research Report: How Sales and Marketing Intelligence Drive Improved Business Outcomes

Those implementing a B2B sales and marketing intelligence solution reported that they have realized 35% more leads in their pipeline and 45% higher-quality leads leading to higher revenue and growth. However, organizations are fighting back - and winning.

article thumbnail

Marketing-Led COVID-19 Growth Strategies: 2022 and Beyond

This is your chance to create unprecedented brand awareness, bring in the best leads sales has ever seen, and play an instrumental role in generating new and existing business revenue. Define and agree on “qualified leads”. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy.

article thumbnail

How to Overcome the Pain Points of Your CRM

Leveraging leading industry research from industry analysts, this eBook explores how your sales team can gain back valuable time with the following: Conquering the most difficult pain points in your CRM. Leading integrations that fit directly into your CRM and workflow. The result? Combatting low adoption rates and data quality.

article thumbnail

The Time-Saving Power of Intent Data for Sales

Read on to learn more about how intent data can save salespeople time -- while capturing more qualified leads in the process! Not only that, but using it will save immense time during your workflow; a win-win on all fronts.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

How AI-powered analytics are leading to more intriguing and satisfying customer interactions. The growing demand among buyers for open marketing platforms that can support “BYOD” (bring your own data).

article thumbnail

16 Go-to-Market Plays for Your Entire Sales Funnel

Nurturing leads through your sales funnel is a daunting task for many business development teams, especially at the scale required to achieve lofty growth goals. But personalized prospecting is possible at scale with the right resources in place. At ZoomInfo, we’ve found that a rock-solid go-to-market playbook is key.

article thumbnail

ABCs of Data Normalization for B2B Marketers

However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot. Data normalization. It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow.